Camp4 Therapeutics Corp 8-K

What Happened

• On May 7, 2026, Camp4 Therapeutics Corporation (CAMP) announced and furnished a press release reporting its financial results for the quarter ended March 31, 2026. The press release was included as Exhibit 99.1 to a Current Report on Form 8-K filed the same day and the report was signed by President and CEO Josh Mandel-Brehm.

Key Details

• Filing: Current Report on Form 8-K filed May 7, 2026 (Item 2.02: Results of Operations and Financial Condition).
• Period covered: Quarter ended March 31, 2026.
• Disclosure included: Press release furnished as Exhibit 99.1; interactive XBRL cover page (Exhibit 104) is embedded.
• Authorized signature: Josh Mandel-Brehm, President and Chief Executive Officer, dated May 7, 2026.

Why It Matters

• The 8-K signals Camp4 has publicly released its latest quarterly results (earnings/revenue/financial condition) — key information investors use to assess near-term performance. The furnished press release (Exhibit 99.1) and embedded XBRL data make the results accessible for review and data analysis. Investors should read the press release and accompanying financial statements for specific revenue, expense, and guidance details that could affect the stock.